论文信息 - Open trial of fluoxetine in obsessive-compulsive disorder.

Open trial of fluoxetine in obsessive-compulsive disorder.

A 12-week open trial of fluoxetine in 61 obsessive-compulsive disorder patients significantly improved depressive and obsessive-compulsive symptoms. Baseline depression scores were not related to improvement on two obsessive-compulsive scales. The results reinforce the hypothesis of serotonergic abnormalities in obsessive-compulsive disorder.

[1] S. Woods,et al. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. , 1988, Archives of general psychiatry.

[2] J. Greist,et al. Fluvoxamine treatment of obsessive-compulsive disorder. , 1987, The American journal of psychiatry.

[3] W. Goodman,et al. Treatment of severe obsessive-compulsive disorder with fluvoxamine. , 1987, The American journal of psychiatry.

[4] G. Chouinard,et al. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. , 1986, Journal of clinical psychopharmacology.

[5] D. Beidel,et al. Fluoxetine treatment of obsessive-compulsive disorder. , 1985, Journal of clinical psychopharmacology.

[6] M. Åsberg,et al. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. , 1980, Archives of general psychiatry.

[7] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.